• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human REXO4 Polyclonal Antibody

The antibody against REXO4 was raised in rabbit using the Human REXO4,REX4 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.

ADC-46531A

The antibody against REXO4 was raised in rabbit using the Human REXO4,REX4 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.

$600.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-46531A ClonalityPolyclonal
Host SpeciesRabbitTarget NameREXO4
Target SynonymsREXO4; PMC2; XPMC2H; RNA exonuclease 4; Exonuclease XPMC2; Prevents mitotic catastrophe 2 protein homolog; hPMC2FormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, Avoid freeze / thaw cycles., PBS with 0.02% sodium azidePurification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, IHC, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionHuman REXO4,REX4Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ9GZR2
Background Information
  • Uniprot Id

    Q9GZR2

  • Target Species

    Human

  • Target Name

    REXO4

  • Target Full Name

    RNA exonuclease 4

  • Target Subcellular Location

    Nucleus, nucleolus.

  • Target Protein Families

    REXO4 family

  • Target Synonyms

    REXO4; PMC2; XPMC2H; RNA exonuclease 4; Exonuclease XPMC2; Prevents mitotic catastrophe 2 protein homolog; hPMC2

Inquire Rabbit anti-Human REXO4 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification